Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Cannara Biotech Inc. (V:LOVE)

Business Focus: Alternative Medicine

INK Edge Outlook

Mostly sunny as of July 01, 2021
For the latest outlook, get the company report

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for LOVE within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jul 09, 2021 08:30 ET
Cannara Biotech Inc. Completes Additional $5 Million Private Placement
MONTREAL, July 9, 2021 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium–grade cannabis and derivative products with two Quebec–based mega cultivation facilities spanning over 1,650,000 sq. ft., today announced that it has closed an additional $5 million private placement at an issue price per share of $0.18, resulting in the issuance of 27,777,778 new common shares in the capital of the Company. This follows the Company's previously-announced acquisition of the one million square foot licensed cultiv
Read full article
Jun 28, 2021 08:35 ET
Cannara Biotech Inc. Reports Preliminary Results Ahead of Third Quarter 2021
Preliminary results from first commercial quarter in market show successful market launch in Quebec
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
30.69
11.84
12.47
Price to Book - most recent quarter
3.77
2.86
3.57
Price to Cash Flow per share - TTM
--
13.00
17.92
Price to Free Cash Flow per share - TTM
--
14.79
29.20
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jul 15, 202169,537-718,217
Jun 30, 2021787,754149,578
Jun 15, 2021638,176538,738
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Cannara Biotech Inc. is a Canada-based vertically integrated cannabis company. The Company's segments include indoor cannabis operations and electronic commerce retail. The indoor cannabis segment's operations include cultivation, processing and sale of dried cannabis and cannabis derivatives for the Quebec and Canadian market. The Company also operates as an electronic commerce retailer of United States hemp-based cannabidiol (CBD) products for the United States market. Its subsidiaries include Cannara Biotech (Quebec) Inc. and ShopCBD.com Inc.

See business summary

 

Twitter

Search (past week) for $LOVE.CA LOVE.V

  • No tweets found